Xiangrong Geng^1*, Chenguang Wang^1*, Thilini Perera^2*, Badeia Saed^2*, Ying Hu^2*, Ashley Wolfe^1*, John C Reneau, MD, PhD³, Carlos A. Murga-Zamalloa, MD² and Ryan A. Wilcox, MD⁴

¹University of Michigan, Ann Arbor, MI
²University of Illinois Chicago, Chicago, IL
³The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁴Division of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, MI

Johannes Adrian Hildebrand, MSc, BSc^1*, Sarah Haebe, MD^2*, Verena Passerini, PhD^2*, Michael Heide^2*, William Keay, PhD^2*, Louisa Adolph, MD^2*, Lukas Ulrich^2*, Natyra Tahiri, MD^2*, Raphael Koch, Prof³, Jessica Duffy^4*, Haley Martin^5*, Liam Hackett^6*, Jeremy Zhang^6*, Christina Ludwig, PhD^7*, Stefanie Wilhelm, PhD^7*, Björn Häupl, PhD^8*, Carmen Doebele, PhD^9*, Michael von Bergwelt-Baildon, MD, PhD^2*, Axel Lechner, MD^10*, Tobias Herold, MD^2*, Christian Kellner, PhD^11*, Martina Rudelius^12*, Thomas Oellerich, Prof. MD^13*, Marc Schmidt-Supprian, Prof^14*, Abner Louissaint, MD, PhD^4*, Matthew S. Davids, MD, MMSc¹⁵ and Oliver Weigert, Prof, MD^2,16

¹Department of Medicine III, LMU University Hospital, LMU Munich, München, Germany
²Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
³Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany
⁴Massachusetts General Hospital, Boston, MA
⁵Department of Pathology, Massachusetts General Hospital, Boston, MA
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Bavarian Center for Biomolecular Mass Spectrometry, Technical University Munich, Munich, Germany
⁸Goethe University, Frankfurt Am Main, Germany
⁹Goethe University, Frankfurt Am Main, DEU
¹⁰Department of Otorhinolaryngology, LMU University Hospital, LMU Munich, Munich, Germany
¹¹Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany
¹²Institute of Pathology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
¹³Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany
¹⁴Institute of Experimental Hematology, TranslaTUM, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
¹⁵Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹⁶German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Alexey Danilov, MD¹, Hongli Li, MS^2*, Mazyar Shadman, MD, MPH², Lisa M. Rimsza, MD³, Ahmad Zebari^4*, Sonali M. Smith⁵, Michael Leblanc^2*, Jonathan W. Friedberg, MD, MMSc⁶, Christopher Carlson^2* and Joo Y Song, MD^7*

¹Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
²Fred Hutchinson Cancer Center, Seattle, WA
³Mayo Clinic Scottsdale, Scottsdale, AZ
⁴Fred Hutchinson Cancer Center, Seattle
⁵Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁶Wilmot Cancer Center, University of Rochester, Rochester, NY
⁷Department of Pathology, City of Hope National Medical Center, Duarte, CA

Melissa A. Hopper, BS, MS¹, Abigail R. Dropik, BS¹, Janek S. Walker, PhD¹, Joseph P. Novak^2*, Miranda S. Laverty^3*, Michelle Manske, MS, BS^1*, Xiaosheng Wu, MD^2*, Kerstin Wenzl, PhD^2*, Jordan Edward Krull^1*, Vivekananda Sarangi^1*, Matthew J. Maurer, DSc⁴, Thomas M. Habermann, MD², Brian K. Link, MD^5*, Lisa M. Rimsza, MD⁶, Thomas E. Witzig, MD¹, Stephen M Ansell, MD, PhD², James R. Cerhan, MD, PhD⁷, Dragan Jevremovic, MD, PhD^8* and Anne J. Novak, PhD²

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester
⁴Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
⁷Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Daniel Joffe^1*, Lauren Banner^1*, Safiyyah Bhatti, MD^2*, Laura Gleason, MD^3*, Jenna Mandel, BS^1*, Pierluigi Porcu, MD^4,5 and Neda Nikbakht, MD^1*

¹Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
²Thomas Jefferson University Hospital, Philadelphia, PA
³Thomas Jefferson University, Philadelphia, PA
⁴Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
⁵Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA

Bachisio Ziccheddu^1*, Michael D. Jain, MD, PhD², Monika Chojnacka, B.S.³, Michael Durante, PhD^1*, Julieta Abraham Miranda, PhD^4*, Meghan Menges^5*, Ola Landgren, MD¹, Marco Davila, MD, PhD⁶, Jonathan H. Schatz, MD⁷, Francesco Maura, MD⁸ and Frederick L. Locke, MD²

¹Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁸Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Tiange Lu^1*, Xiangxiang Zhou^2*, Juan Yang^1*, Yiqing Cai^1*, Mengfei Ding^1*, Xiaomin Chen^1*, Zhuoya Yu^1*, Xiaosheng Fang^2* and Xin Wang, MD, PhD¹

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

Clara C Chamba, MD, MMed^1*, Kieran Howard^2*, William F Mawalla, MD^1*, Heavenlight Christopher, MSc^1*, Julius Seruyange^3*, Emmanuel Josephat, MSc^1*, Ismail D Legason, MSc, BSc, MPH^4*, Martin Ogwang^4*, Alisen Ayitewala, MSc^3*, Alex Mremi, PhD^5*, Caroline Achola, MBChB, MMed(Path)^3*, Edrick Elias^6,7*, Anthony Cutts^2*, Helene Dreau, MSc^2*, Adam Burns, PhD^2*, Rehema Shungu^8*, Sila Gerlevik^2*, Daisy Jennings, MSc^9*, Emmanuel Balandya^10*, Kate Ridout, PhD^2*, Hadija Mwamtemi, MD, MMed^11*, Priscus Mapendo^12*, Eli Mkwizu^12*, Claire El Mouden, DPhil^2*, Dimitris Vavoulis^2*, Anna Schuh, MD, PhD, FRCP, FRCPath² and AI-Real Consortium^{2,3,4,7,8,11,12*}

¹Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania, United Republic of
²Department of Oncology, University of Oxford, Oxford, United Kingdom
³Central Public Health Laboratories, Kampala, Uganda
⁴St. Mary's Hospital Lacor, Gulu, Uganda
⁵Kilimanjaro Christian Medical Centre, Moshi, Tanzania, United Republic of
⁶Catholic University of Health and Allied Sciences, Mwanza, Tanzania, United Republic of
⁷Bugando Medical Centre, Mwanza, Tanzania, United Republic of
⁸Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania, United Republic of
⁹Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
¹⁰Department of Physiology, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania, United Republic of
¹¹Department of Paediatrics, Muhimbili National Hospital, Dar-es-Salaam, Tanzania, United Republic of
¹²Department of Oncology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania, United Republic of

Henna S. Nam, BS^*, Yusuke Isshiki, MD, PhD, Min Xia, PhD, Sanket Shah, PhD^*, Meng Li, PhD^*, Ioannis Karagiannidis, PhD^*, Matthew Teater, PhD^*, Ari M Melnick, MD and Wendy Beguelin, PhD^*

Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

Lei Nie, MD^1*, Vivian Changying Jiang, PhD¹, Yang Liu, PhD^1*, Joseph McIntosh, BS^2*, Jovanny Vargas^3*, Qingsong Cai, PhD^4* and Michael L. Wang, MD^5,6

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Lymphoma & Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX
³Lymphoma Myeloma, The University of Texas MD Anderson Cancer Center, houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX
⁶Lymphoma/ Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Dailia B. Francis, MD, PhD^1,2, Jodi Dougan, B.S.^1*, Claire Pillsbury, PhD^1*, Sunita Park, MD^3*, Solomon Langermann, PhD^4*, Jean L. Koff, MD, MSc⁵, Ziyi Li, PhD^6*, Christopher R. Flowers, MD, MS⁷ and Christopher C. Porter, MD^1,2*

¹Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
²Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA
³Department of Hematopathology, Children's Healthcare of Atlanta, Atlanta, GA
⁴NextCure, Beltsville, MD
⁵Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Yuting Yan^1*, Xinzhou Ge^2*, Jian Sun^3*, Lei Yu^4*, Qunling Zhang, MD, PhD^5*, Ying Yu^6*, Zhenyu Jia, PhD^7*, Dehui Zou^8*, Jessica Li^2*, Lugui Qiu¹, Lili Wang, MD/PhD⁹ and Shuhua Yi^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²University of California, Los Angeles
³Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁴University of California, Riverside
⁵fudan university, shanghai, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Cent, Tianjin, China
⁷Department of Botany and Plant Sciences, University of California Riverside, Riverside, CA
⁸Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁹Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA

Cédric Rossi, MD, PhD^1,2, Jan Boegeholz, MD³, Stefan K. Alig, MD⁴, Andrea Garofalo⁴, Mohammad Shahrokh Esfahani, PhD^4*, Joseph Schroers-Martin, MD^5*, Mari Olsen^4*, Xiaoman Kang^4*, David M. Kurtz, MD, PhD⁴, Takeshi Sugio, MD, PhD^1*, Mark P. Hamilton, MD⁶, Marc Andre, MD^7*, Rene-Olivier Casasnovas, MD^8*, Luc Matthieu Fornecker^9*, Maximilian Diehn, MD, PhD^10*, Herve Ghesquieres, MD, PhD^11,12* and Ash A. Alizadeh, MD, PhD⁴

¹Stanford University, Stanford, CA
²CHU Dijon, Dijon, France
³Stanford Univesiry, Stanford, CA
⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁵Divisions of Hematology and Oncology, Stanford University, Stanford, CA
⁶Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁷Department of Hematology, Clinique de Mont-Godinne, Yvoir, Belgium
⁸CHU DE DIJON - HÔPITAL F. MITTERRAND, Dijon, FRA
⁹Hematology, ICANS, Strasbourg, FRA
¹⁰Department of Radiation Oncology, Stanford University, Stanford, CA
¹¹University of Lyon, Lyon, FRA
¹²Hematology Department, Hopital Lyon Sud - HCL, Lyon, France

Helen Parker^1*, Amatta Mirandari^1*, Carolina Jaramillo-Oquendo^2*, Marti Duran-Ferrer^3*, Ben Stevens^1*, Lara Buermann^1*, Harindra Eranthi Amarasinghe, PhD^1,4*, Jaya Thomas^1*, Louise J. Carr, MSc^1*, Shama Syeda^1*, Methusha Sakthipakan^1*, Marina Parry^1*, Zadie Davies^5*, Neil McIver-Brown^5*, Aliki Xochelli, MD^6*, Sarah Ennis^2*, Lydia Scarfo, MD⁷, Paolo Ghia, MD, PhD⁸, Christina H. Kalpadakis, MD^9*, Gerassimos Pangalis, MD^10*, Davide Rossi¹¹, Simon Wagner^12*, Matthew Ahearne^12*, Marc Seifert^13*, Christoph Plass^14*, Dieter Weichenhan^14*, Eva Kimby^15*, Lesley Ann Sutton, PhD, BSc^16*, Richard Rosenquist, MD¹⁷, Francesco Forconi^1*, Kostas Stamatopoulos^6*, Marta Salido, PhD^18*, Ana Ferrer, MD, PhD^19*, Catherine Thieblemont, MD^20*, David Graham Oscier, MD, PhD²¹, Renata Walewska^22*, Matthew JJ Rose-Zerilli^1*, Jane Gibson, PhD^1*, Iñaki I. Martin Subero, PhD^3,23*, Christopher C. Oakes, PhD²⁴, Dean J. Bryant, PhD^1* and Jonathan C. Strefford, BSc²⁵

¹School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
²Genomic Informatics, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
³Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
⁴Radcliffe Department of Investigative Medicine, University of Oxford, Oxford, United Kingdom
⁵Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom
⁶Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
⁷Laboratory of B-cell Neoplasia, IRCCS Ospedale San Raffaele, Milano, Italy
⁸Unit of B Cell Neoplasia and Strategic Research Program on CLL, Università Vita-Salute and IRCCS Ospedale San Raffaele, Milan, Italy
⁹University Hospital of Crete, Heraklion, Crete, GRC
¹⁰Department of Haematology, Athens Medical Center, Athens, GRC
¹¹Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
¹²Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, United Kingdom
¹³Institut fur zellbiologie, Universitatsklinikum Essen, Essen, DEU
¹⁴Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁵Division of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden
¹⁶Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
¹⁷Karolinska Institutet, Stockholm, Sweden
¹⁸Laboratori de Citogenètica, Servei de Patologia, Hospital del Mar, GRETNHE, IMIM, Barcelona, Spain
¹⁹Laboratori de Citologia Hematològica, Servei de Patologia, Hospital del Mar, GRETNHE, IMIM, Barcelona, Spain
²⁰Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France
²¹Division of Haematology, University Hospitals Dorset, Bournemouth, United Kingdom
²²Department of Haematology, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom
²³Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
²⁴Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²⁵School of Cancer Sciences, Faculty of Medicine, Univ. of Southampton, Southampton, United Kingdom

Hua-Jay Jeffery Cherng, MD¹, Xiaojing Yang, PhD^2*, Ryan Yancey, MS^2*, Christian A Gordillo, BSc^3*, Ted B. Piorczynski, PhD^4*, Hei T. Chan, RN^5*, Kenneth N. Ofori, MHS, MD^6,7*, Govind Bhagat, MD⁷, Andrea Califano, PhD^8*, Barbara Pro, MD⁹, Keith Booher, PhD^2*, Jennifer E. Amengual, MD¹, Ran Reshef, MD, MSc¹⁰ and Abu A. I. Sina, PhD^8*

¹Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
²Zymo Research, Irvine
³Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY
⁴Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY
⁵Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York
⁶Indiana University Health, Indianapolis
⁷Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York
⁸Department of Systems Biology, Columbia University Irving Medical Center, New York
⁹Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
¹⁰Division of Hematology & Oncology, Columbia University Medical Center, New York

Haisheng Liu^1*, Yue Yuan^2*, Lili Wu^1*, Lanping Diao^1*, Yuhuan Gao, MD^1*, Chengcheng Wang^2*, Pingping Zou^2*, Shanbo Cao^2* and Jiayue Qin, PhD^2*

¹the Fourth Hospital of Hebei Medical University, Shijiazhuang, China
²Acornmed Biotechnology Co., Ltd., Beijing, China

Elisa Genuardi^1*, Beatrice Alessandria^1*, Irene Della Starza, PhD^2*, Francesca Guerrini^3*, Riccardo Bomben^4*, Daniela Drandi^1*, Martina Ferrante^1*, Clara Bono^3*, Roberta Soscia^5*, Tamara Bittolo^4*, Simone Ragaini^1,6*, Salvatrice Mancuso^7*, Emanuele Cencini, MD^8*, Nicola Di Renzo, MD^9*, Clara Mannarella^10*, Marco Murineddu^11*, Vittorio Stefoni^12*, Riccardo Centurioni^13*, Luca Baldini^14*, Aurora Maria Civita^1*, Valter Gattei, MD¹⁵, Sara Galimberti, MD, PhD^3*, Ilaria Del Giudice^5*, Benedetto Bruno, MD, PhD^6,16, Massimo Federico, MD¹⁷, Marco Ladetto¹⁸, Christiane Pott^19,20*, Stefano Luminari, MD²¹ and Simone Ferrero, MD^1,6

¹Division of Hematology ,Department of Molecular Biotechologies and Health Sciences, University of Torino, Torino, Italy
²Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
³Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
⁴CRO Aviano National Cancer Institute,Clinical and Experimental Onco-Hematology Unit, Aviano, Italy
⁵Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
⁶Division of Hematology and Stem cell transplant unit, AOU Città della Salute e della Scienza, Torino, Italy
⁷Policlinico Paolo Giaccone, Unit of Haematology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy
⁸Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
⁹Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, Italy
¹⁰Hematology Unit, Ospedale Madonna delle Grazie, Matera, Italy
¹¹Hematology & Bone Marrow Transplant Unit, Ospedale San Francesco, Nuoro, Italy
¹²Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
¹³U.O.C. Medicina Interna Civitanova Marche, Civitanova Marche, Italy
¹⁴Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy
¹⁵Centro Di Riferimento Oncologico, Aviano, Italy
¹⁶Division of Hematology, Department of Molecular Biotechologies and Health Sciences, University of Torino, Torino, Italy
¹⁷CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy
¹⁸Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁹on behalf of the EuroClonality-NGS Working Group, Kiel, Germany
²⁰Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
²¹Clinics and Public Health, “Arcispedale S.Maria Nuova”, University of Modena e Reggio Emilia, Hematology Division, Department of Diagnostic Medicine, Reggio Emilia, Italy

Pavel Klener Jr.^1,2*, Lenka Daumová^1*, Dmitry Kazantsev, PhD^3*, Ladislav Anděra^4*, Jiří Petrák^5*, Alexandra Dolníková^6*, Nardjas Bettazová^1*, Petra Kovaříková^1,7*, Nicol Renešová^1*, Liliana Tušková^1,8*, Dana Sovilj^4*, Marek Trněný, MD⁹, Magdalena Klanova^1,10* and Ondrej Havránek⁵

¹First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Praha 2, Czech Republic
²First Dept. of Internal Medicine- Hematology, University General Hospital in Prague and First Faculty of Medicine, Charles University, Praha 2, Czech Republic
³First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic
⁴Institute of Biotechnology CAS, BIOCEV, Vestec, Czech Republic
⁵First Faculty of Medicine, BIOCEV, Charles University, Vestec, Czech Republic
⁶First Faculty of Medicine, Charles University, Prague, Czech Republic
⁷First Dept. of Internal Medicine- Hematology, University General Hospital Prague, Praha 2, Czech Republic
⁸First Dept. of Internal Medicine- Hematology, University General Hospital, Praha 2, Czech Republic
⁹First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
¹⁰First Dept. of Internal Medicine- Hematology, General University Hospital, Charles University, Prague 2, AL, Czech Republic

Damien Vasseur^1*, Samuel Abbou^1*, Ludovic Lacroix^1*, Laurence Lamant^2*, Pata-Merci Noémie^1*, David Sibon, MD, PhD^3*, Francesco Facchinetti^1*, Marc Deloger^1*, Floriane Braye^1*, Veronique Minard-Colin, MD, PhD^1*, Laurence Brugières^1*, Etienne Rouleau^1*, Luc Friboulet^1* and Charlotte Rigaud, MD^1*

¹Gustave Roussy, Villejuif, France
²Institut Universitaire Du Cancer Toulouse Oncopole, Toulouse, FRA
³APHP, Paris, FRA

Mayur S. Narkhede, MBBS¹, Sarah Tomassetti^2*, Madiha Iqbal, MD³, Antony Tin, PhD^4*, Samuel Rivero-Hinojosa, PhD^4*, Giby V. George, MD^4*, Hayley Widden, PhD^4*, Ryan Benrud, PA-C^4*, Angel Rodriguez, MD^4* and Minetta C. Liu, MD^4*

¹Department of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL
²Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA, Los Angeles, CA
³Mayo Clinic Florida, Jacksonville, FL
⁴Natera, Inc., Austin, TX

Fangfang Yan, PhD^1*, Vivian Changying Jiang, PhD¹, Yang Liu, PhD^1*, Yijing Li, BS, MS^1*, Yuxuan Che, PhD^1*, Preetesh Jain, MD, MBBS, PhD, DM², Lukas Simon, PhD^3* and Michael Wang, MD^1,4

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Baylor College of Medicine, University, Houston, TX
⁴Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Matthew Cring^1*, George Widhopf, PhD^2*, Emanuela M. Ghia, PhD^2* and Thomas J. Kipps, MD, PhD^3,4

¹Moores Cancer Center, University of California San Diego, La Jolla, CA
²Center for Novel Therapeutics, Moores Cancer Center, La Jolla, CA
³Center for Novel Therapeutics, University of California, San Diego Moores Cancer Center, La Jolla, CA
⁴Center for Novel Therapeutics, La Jolla, CA